Tarek Chbouki

Array ( [id] => 4409666 [patent_doc_number] => 06265393 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Prevention of endometriosis signs or symptons' [patent_app_type] => 1 [patent_app_number] => 9/130880 [patent_app_country] => US [patent_app_date] => 1998-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 8736 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265393.pdf [firstpage_image] =>[orig_patent_app_number] => 130880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3928258 [patent_doc_number] => 05972317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Composition and method for treating diseased nails' [patent_app_type] => 1 [patent_app_number] => 9/130132 [patent_app_country] => US [patent_app_date] => 1998-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 8676 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972317.pdf [firstpage_image] =>[orig_patent_app_number] => 130132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6604727 [patent_doc_number] => 20020015732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'FORMULATION OF A 5 ALPHA REDUCTASE INHIBITOR FOR ORAL ADMINISTRTION, AND A PREPARATION PROCESS AND USE THEREOF' [patent_app_type] => new [patent_app_number] => 09/128861 [patent_app_country] => US [patent_app_date] => 1998-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4415 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20020015732.pdf [firstpage_image] =>[orig_patent_app_number] => 09128861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531195 [patent_doc_number] => 06410053 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Reversible cross-linked gel' [patent_app_type] => B1 [patent_app_number] => 09/124445 [patent_app_country] => US [patent_app_date] => 1998-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 2287 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410053.pdf [firstpage_image] =>[orig_patent_app_number] => 09124445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1506129 [patent_doc_number] => 06440460 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Pharmaceutical compositions containing buffered ortho ester polymers' [patent_app_type] => B1 [patent_app_number] => 09/117359 [patent_app_country] => US [patent_app_date] => 1998-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3961 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440460.pdf [firstpage_image] =>[orig_patent_app_number] => 09117359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631264 [patent_doc_number] => 06635668 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Imidazoline receptor binding compounds' [patent_app_type] => B1 [patent_app_number] => 09/120584 [patent_app_country] => US [patent_app_date] => 1998-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6906 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635668.pdf [firstpage_image] =>[orig_patent_app_number] => 09120584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1020883 [patent_doc_number] => 06887490 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Gene therapy vehicle comprising dermal sheath tissue' [patent_app_type] => utility [patent_app_number] => 09/463174 [patent_app_country] => US [patent_app_date] => 1998-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 27 [patent_no_of_words] => 7874 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887490.pdf [firstpage_image] =>[orig_patent_app_number] => 09463174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297276 [patent_doc_number] => 06251434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Preparations of non-steroidal analgesics' [patent_app_type] => 1 [patent_app_number] => 9/101694 [patent_app_country] => US [patent_app_date] => 1998-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2140 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251434.pdf [firstpage_image] =>[orig_patent_app_number] => 101694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046953 [patent_doc_number] => 20020168408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'SYNTHETIC PARTICULATE VECTORS AND PREPARATION PROCESS' [patent_app_type] => new [patent_app_number] => 09/112367 [patent_app_country] => US [patent_app_date] => 1998-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6744 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168408.pdf [firstpage_image] =>[orig_patent_app_number] => 09112367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4149442 [patent_doc_number] => 06103258 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Salts and bases of the 17-(Cyclopropylmethyl)-4,5 alpha-epoxy-6-Methylenemorphinan-3,14 diol molecule for optimizing dopamine homeostasis during administration of opioid analgesics' [patent_app_type] => 1 [patent_app_number] => 9/111068 [patent_app_country] => US [patent_app_date] => 1998-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6400 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103258.pdf [firstpage_image] =>[orig_patent_app_number] => 111068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6654212 [patent_doc_number] => 20030077295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'DENDRITIC-PLATINATE DRUG DELIVERY SYSTEM' [patent_app_type] => new [patent_app_number] => 09/111232 [patent_app_country] => US [patent_app_date] => 1998-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7291 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077295.pdf [firstpage_image] =>[orig_patent_app_number] => 09111232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4401885 [patent_doc_number] => 06171615 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Sustained release theophylline formulations, excipient systems and methods of production' [patent_app_type] => 1 [patent_app_number] => 9/110599 [patent_app_country] => US [patent_app_date] => 1998-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 4885 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171615.pdf [firstpage_image] =>[orig_patent_app_number] => 110599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4298065 [patent_doc_number] => 06187337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Rapidly dissolving dosage form' [patent_app_type] => 1 [patent_app_number] => 9/111115 [patent_app_country] => US [patent_app_date] => 1998-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14816 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187337.pdf [firstpage_image] =>[orig_patent_app_number] => 111115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4245095 [patent_doc_number] => 06207199 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Process for making a particulate support matrix for making a rapidly dissolving dosage form' [patent_app_type] => 1 [patent_app_number] => 9/110790 [patent_app_country] => US [patent_app_date] => 1998-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14819 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207199.pdf [firstpage_image] =>[orig_patent_app_number] => 110790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4417153 [patent_doc_number] => 06177104 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Particulate support matrix for making a rapidly dissolving dosage form' [patent_app_type] => 1 [patent_app_number] => 9/111124 [patent_app_country] => US [patent_app_date] => 1998-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14826 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177104.pdf [firstpage_image] =>[orig_patent_app_number] => 111124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388097 [patent_doc_number] => 06541033 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Thermosensitive biodegradable hydrogels for sustained delivery of leptin' [patent_app_type] => B1 [patent_app_number] => 09/107603 [patent_app_country] => US [patent_app_date] => 1998-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6764 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541033.pdf [firstpage_image] =>[orig_patent_app_number] => 09107603 [rel_patent_id] =>[rel_patent_doc_number] =>)